Efficacy of rituximab as a single-agent therapy for the treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency (CVID) (Q58610647)
Jump to navigation
Jump to search
scientific article published on 05 November 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy of rituximab as a single-agent therapy for the treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in patients with Common Variable Immunodeficiency (CVID) |
scientific article published on 05 November 2018 |
Statements
Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency (English)
Riccardo De Carli
Rossano Girometti
Alessandro De Pellegrin
Federico Reccardini
Barbara Frossi